This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmed, S. Articles by McMahon-Pratt, D. Search for Related Content PubMed PubMed Citation Articles by Ahmed, S. Articles by McMahon-Pratt, D. Pubmed/NCBI databases Medline Plus Health Information Leishmaniasis

Intradermal Infection Model for Pathogenesis and Vaccine Studies of Murine Visceral Leishmaniasis

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520-8034,¹ Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1019,² WHO Collaborating Center for Leishmaniasis, Servicio de Parasitologia, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Spain³

Received 26 March 2002/ Returned for modification 20 May 2002/ Accepted 3 October 2002

The levels of protection found in vaccine studies of murine visceral leishmaniasis are significantly lower than for cutaneous leishmaniasis; whether this is due to the high-challenge murine model employed and/or is a consequence of differences required in tissue-specific local immune responses is not understood. Consequently, an intradermal murine model of visceral leishmaniasis has been explored. Intradermal inoculation established a chronic infection in susceptible mice which was associated with a pattern of parasite clearance with time postinfection in the liver and skin; in contrast, parasite persistence and expansion was observed in lymphoid tissue (spleen and draining lymph node). The course of disease found appears to be similar to those reported for subclinical canine and human visceral leishmaniasis. Clearance of parasites from the skin was correlated with an inflammatory response and the infiltration and activation of CD4⁺ and CD8⁺ T cells. In contrast, in lymphoid tissue (lymph node or spleen), the production of Th1/Th2 cytokines (interleukin-4 [IL-4], IL-10, and gamma interferon) appeared to correlate with parasite burden and pathogenesis. In vaccination experiments employing the Leishmania infantum D-13 (p80) antigen, significantly higher levels of protection were found with the intradermal murine model (29 to 7,500-fold more than naive controls) than were found with a low-dose intravenous infection model (9 to 173-fold). Thus, this model should prove useful for further investigation of disease pathogenesis as well as vaccine studies of visceral leishmaniasis.

Editor: J. M. Mansfield

This article has been cited by other articles:

• McFarlane, E., Perez, C., Charmoy, M., Allenbach, C., Carter, K. C., Alexander, J., Tacchini-Cottier, F. (2008). Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani. Infect. Immun. 76: 532-541 [Abstract] [Full Text]  
• Stevenson, H. L., Jordan, J. M., Peerwani, Z., Wang, H.-Q., Walker, D. H., Ismail, N. (2006). An Intradermal Environment Promotes a Protective Type-1 Response against Lethal Systemic Monocytotropic Ehrlichial Infection.. Infect. Immun. 74: 4856-4864 [Abstract] [Full Text]  
• Campos-Martin, Y., Colmenares, M., Gozalbo-Lopez, B., Lopez-Nunez, M., Savage, P. B., Martinez-Naves, E. (2006). Immature Human Dendritic Cells Infected with Leishmania infantum Are Resistant to NK-Mediated Cytolysis but Are Efficiently Recognized by NKT Cells. J. Immunol. 176: 6172-6179 [Abstract] [Full Text]  
• Rama Iniguez, S., Dea-Ayuela, M. A., Sanchez-Brunete, J. A., Torrado, J. J., Alunda, J. M., Bolas-Fernandez, F. (2006). Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation.. Antimicrob. Agents Chemother. 50: 1195-1201 [Abstract] [Full Text]  
• Breton, M., Tremblay, M. J, Ouellette, M., Papadopoulou, B. (2005). Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis. Infect. Immun. 73: 6372-6382 [Abstract] [Full Text]  
• Dondji, B., Perez-Jimenez, E., Goldsmith-Pestana, K., Esteban, M., McMahon-Pratt, D. (2005). Heterologous Prime-Boost Vaccination with the LACK Antigen Protects against Murine Visceral Leishmaniasis. Infect. Immun. 73: 5286-5289 [Abstract] [Full Text]  
• Colmenares, M., Corbi, A. L., Turco, S. J., Rivas, L. (2004). The Dendritic Cell Receptor DC-SIGN Discriminates among Species and Life Cycle Forms of Leishmania. J. Immunol. 172: 1186-1190 [Abstract] [Full Text]